{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:36:48Z","timestamp":1777635408322,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"IUPUI-BBRC funding mechanism","award":["S10-RR023710"],"award-info":[{"award-number":["S10-RR023710"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.matbio.2015.12.008","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T10:49:23Z","timestamp":1450522163000},"page":"19-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta"],"prefix":"10.1016","volume":"52-54","author":[{"given":"Alycia G.","family":"Berman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary R.","family":"Bart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.matbio.2015.12.008_bb0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/geno.1994.1141","article-title":"Confirmation of a G nucleotide deletion in the Cola-2 gene of mice with the osteogenesis imperfecta mutation","volume":"20","author":"McBride","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.matbio.2015.12.008_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.matbio.2015.12.008_bb0015","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jsb.2012.09.012","article-title":"Effects of tissue hydration on nanoscale structural morphology and mechanics of individual Type I collagen fibrils in the Brtl mouse model of Osteogenesis Imperfecta","volume":"180","author":"Kemp","year":"2012","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.matbio.2015.12.008_bb0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jsb.2010.08.003","volume":"173","author":"Wallace","year":"2011","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.matbio.2015.12.008_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jbmr.5650080203","article-title":"Collagen crosslinks and mineral crystallinity in bone of patients with osteogenesis imperfecta","volume":"8","author":"Vetter","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0030","doi-asserted-by":"crossref","first-page":"257-257","DOI":"10.1002\/ajmg.1320450220","article-title":"Collagen fibrils of osteoid in osteogenesis imperfecta: morphometrical analysis of the fibril diameter","volume":"45","author":"St\u00f6ss","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.matbio.2015.12.008_bb0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1359\/jbmr.1999.14.2.264","article-title":"The material basis for reduced mechanical properties in oim mice bones","volume":"14","author":"Camacho","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/03008207.2014.923860","article-title":"Multi-scale analysis of bone chemistry, morphology and mechanics in the oim model of osteogenesis imperfecta","volume":"55","author":"Bart","year":"2015","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0045","series-title":"Animal Models of Osteogenesis Imperfecta","first-page":"1","author":"Sathyanarayanan","year":"2013"},{"key":"10.1016\/j.matbio.2015.12.008_bb0050","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.matbio.2015.12.008_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.matbio.2015.12.008_bb0060","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1542\/peds.2006-2023I","article-title":"Experience with bisphosphonates in osteogenesis imperfecta","volume":"119","author":"Glorieux","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.matbio.2015.12.008_bb0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.matbio.2015.12.008_bb0070","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","article-title":"Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"24","author":"Rauch","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1359\/jbmr.090712","article-title":"A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta","volume":"25","author":"Bishop","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0080","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study","volume":"20","author":"Gatti","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0085","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.matbio.2015.12.008_bb0090","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","article-title":"Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"96","author":"Ward","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.matbio.2015.12.008_bb0100","series-title":"Bisphosphonate therapy for osteogenesis imperfecta (Review)","first-page":"1","author":"Dwan","year":"2014"},{"key":"10.1016\/j.matbio.2015.12.008_bb0105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.081238","article-title":"Alendronate treatment of the Brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation","volume":"24","author":"Uveges","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2004.10.006","article-title":"Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse","volume":"36","author":"Misof","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.matbio.2015.12.008_bb0115","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-011-1742-7","article-title":"Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta","volume":"23","author":"Bargman","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.matbio.2015.12.008_bb0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.matbio.2015.12.008_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jbmr.1717","article-title":"Sclerostin antibody improves skeletal parameters in a Brtl\/+ mouse model of osteogenesis imperfecta","volume":"28","author":"Sinder","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0130","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1185\/03007995.2011.606312","article-title":"Long-term raloxifene for postmenopausal osteoporosis","volume":"27","author":"Recker","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.matbio.2015.12.008_bb0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00198-005-2030-1","article-title":"Anti-vertebral fracture efficacy of raloxifene: a meta-analysis","volume":"17","author":"Seeman","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.matbio.2015.12.008_bb0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bone.2014.01.009","article-title":"Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties","volume":"61","author":"Gallant","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.matbio.2015.12.008_bb0145","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/jbmr.2470","article-title":"In vivo UTE-MRI reveals positive effects of raloxifene on skeletal-bound water in skeletally mature beagle dogs","volume":"30","author":"Allen","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0150","article-title":"Raloxifene improves skeletal properties in an animal model of chronic kidney disease","author":"Newman","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.matbio.2015.12.008_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/JCI71101","article-title":"Evaluation of teriparatide treatment in adults with osteogenesis imperfecta","author":"Orwoll","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2015.12.008_bb0160","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2014-3072","article-title":"Effect of denosumab on the growing skeleton in osteogenesis imperfecta","volume":"99","author":"Hoyer-Kuhn","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.matbio.2015.12.008_bb0165","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jbmr.2172","article-title":"How tough is brittle bone? Investigating osteogenesis imperfecta in mouse bone","volume":"29","author":"Carriero","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1359\/JBMR.040111","article-title":"Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength","volume":"19","author":"Kozloff","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2015.12.008_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.10.012","article-title":"Rapidly growing Brtl\/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment","volume":"71","author":"Sinder","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.matbio.2015.12.008_bb0180","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1210\/en.2007-0275","article-title":"Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone","volume":"148","author":"Allen","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.matbio.2015.12.008_bb0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00223-015-9977-5","article-title":"The role of water compartments in the material properties of cortical bone","volume":"97","author":"Granke","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.matbio.2015.12.008_bb0190","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/nbm.3316","article-title":"Ultrashort echo time magnetization transfer (UTE-MT) imaging of cortical bone","volume":"28","author":"Chang","year":"2015","journal-title":"NMR Biomed."},{"key":"10.1016\/j.matbio.2015.12.008_bb0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bone.2007.09.049","article-title":"Measurements of mobile and bound water by nuclear magnetic resonance correlate with mechanical properties of bone","volume":"42","author":"Nyman","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.matbio.2015.12.008_bb0200","first-page":"140336","article-title":"In vivo quantitative MR imaging of bound and pore water in cortical bone","author":"Manhard","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.matbio.2015.12.008_bb0205","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1148\/radiol.2482071995","article-title":"Cortical bone water: in vivo quantification with ultrashort echo-time MR imaging","volume":"248","author":"Techawiboonwong","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.matbio.2015.12.008_bb0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002230010045","article-title":"A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta","volume":"69","author":"Camacho","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.matbio.2015.12.008_bb0215","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2010-05-287565","article-title":"Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties","volume":"117","author":"Vanleene","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.matbio.2015.12.008_bb0220","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2007-08-105809","article-title":"Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice","volume":"111","author":"Guillot","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.matbio.2015.12.008_bb0225","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S8756-3282(02)00974-2","article-title":"Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta","volume":"32","author":"Evans","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.matbio.2015.12.008_bb0230","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/joim.12339","article-title":"Efficacy, effectiveness and side effects of medications used to prevent fractures","volume":"277","author":"Reid","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.matbio.2015.12.008_bb0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bone.2005.12.081","article-title":"The mechanical phenotype of biglycan-deficient mice is bone-and gender-specific","volume":"39","author":"Wallace","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.matbio.2015.12.008_bb0240","doi-asserted-by":"crossref","first-page":"e0130504","DOI":"10.1371\/journal.pone.0130504","article-title":"Structural and mechanical improvements to bone are strain dependent with axial compression of the tibia in female C57BL\/6 mice","volume":"10","author":"Berman","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.matbio.2015.12.008_bb0245","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbmr.2356","article-title":"Bone fracture toughness and strength correlate with collagen cross-link maturity in a dose-controlled lathyrism mouse model","volume":"30","author":"McNerny","year":"2015","journal-title":"J. Bone Miner. Res."}],"container-title":["Matrix Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X15300111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X15300111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T01:35:00Z","timestamp":1572744900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0945053X15300111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":49,"alternative-id":["S0945053X15300111"],"URL":"https:\/\/doi.org\/10.1016\/j.matbio.2015.12.008","relation":{},"ISSN":["0945-053X"],"issn-type":[{"value":"0945-053X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.matbio.2015.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}